相关实验视频

Updated: Jun 22, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

电子警报,以改善氨酸诱导的血小板缺血症的管理

Rebecca L Zon^1,2,3, Katelyn W Sylvester⁴, David Rubins^3,5

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Research and practice in thrombosis and haemostasis

|July 2, 2024

概括

电子健康记录提醒改善了氨酸诱导的血小板缩 (HIT) 的诊断和管理. 这些干预措施减少了肝素的使用,并增加了适当的测试,从而改善了HIT患者的护理.

科学领域:

医疗信息学医疗信息学
临床病理学临床病理学
提高质量提高质量

背景情况:

肝素诱导的血小板缺血 (HIT) 存在诊断和治疗方面的挑战,延迟可能会增加患者的发病率和死亡率.
准确和及时的诊断对于有效的HIT管理至关重要.

研究的目的:

通过基于电子健康记录 (EHR) 的警报干预措施,增强素诱导的血小板缩 (HIT) 的诊断和管理.
促进基于指导方针的,对疑似HIT进行准确的护理.

主要方法:

一项质量改进计划在一个学术医疗中心实施了三项基于EHR的干预措施.
干预措施包括停止治疗肝素的中断警报,用于HIT测试的综合4T得分计算,以及针对不必要测试的警报.
通过比较干预前和干预后的数据来评估实践变化.

主要成果:

第一个干预措施使在疑似HIT病例中持续使用肝素的比例从65%降至54% (P = .015).
第二次干预显著增加了适当的肝素-PF4测试,从40.4%增加到79.1% (P < .00001).
第三次干预没有显著减少不适当的HIT测试.

结论:

基于EHR的干预措施,包括诊断和管理警报,改善了HIT护理的准则遵守.
该研究表明,在怀疑HIT时,成功实施了4T得分计算和停止肝素治疗.
这些干预措施有助于在临床实践中更准确,更有效地管理HIT.

关键词:

肝素是一种肝素.医疗订单输入系统系统质量改善质量改善血小板细胞减少症 (Thrombocytopenia) 是一种

更多相关视频

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...